Skip to main content

De-stress Pain Management: Rethinking Opioid and Non-Opioid Therapies

This program is free to all healthcare providers regardless of ACOFP membership.

The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.

  • Recall the 12 recommendations for clinicians who are prescribing opioids from the CDC Clinical Practice Guidelines for Prescribing Opioids for Pain, 2022.
  • Explain strategies to facilitate safe integration of opioid analgesics into treatment plans with considerations for consistent patient education.
  • Detail strategies to facilitate tapering of opioids following evidence-based practices.
  • Characterize key clinical presentations of patients at risk for opioid disorder or who may be inappropriately using opioids.
  • Review strategies for implementing OMT into treatment regimens.

Join Live Case Forums
Register for a live case forum to complete the training from this CME program. Dates include (click links below for more information and to register):*Separate registration costs for the events the case forum is held at, virtual case forums are free.

Disclosure Statements
ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff.
ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships.

No relevant financial relationships were identified for any individual in control of content for this specific activity series.

CME Credit and Designation Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians.

ACOFP designates this enduring activity series for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

ACOFP designates this enduring activity series for a maximum of 6 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program.

As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.

Support Acknowledgement
The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.

To submit questions to the presenter please send them to and include the conference and course title so we can direct them correctly.